NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Integrated Medical Model (IMM) Project Verification, Validation, and Credibility (VVandC)The Integrated Medical Model (IMM) Project supports end user requests by employing the Integrated Medical Evidence Database (iMED) and IMM tools as well as subject matter expertise within the Project. The iMED houses data used by the IMM. The IMM is designed to forecast relative changes for a specified set of crew health and mission success risk metrics by using a probabilistic model based on historical data, cohort data, and subject matter expert opinion. A stochastic approach is taken because deterministic results would not appropriately reflect the uncertainty in the IMM inputs. Once the IMM was conceptualized, a plan was needed to rigorously assess input information, framework and code, and output results of the IMM, and ensure that end user requests and requirements were considered during all stages of model development and implementation, as well as lay the foundation for external review and application. METHODS: In 2008, the Project team developed a comprehensive verification and validation (VV) plan, which specified internal and external review criteria encompassing 1) verification of data and IMM structure to ensure proper implementation of the IMM, 2) several validation techniques to confirm that the simulation capability of the IMM appropriately represents occurrences and consequences of medical conditions during space missions, and 3) credibility processes to develop user confidence in the information derived from the IMM. When the NASA-STD-7009 (7009) [1] was published, the Project team updated their verification, validation, and credibility (VVC) project plan to meet 7009 requirements and include 7009 tools in reporting VVC status of the IMM. Construction of these tools included meeting documentation and evidence requirements sufficient to meet external review success criteria. RESULTS: IMM Project VVC updates are compiled recurrently and include updates to the 7009 Compliance and Credibility matrices. Reporting tools have evolved over the lifetime of the IMM Project to better communicate VVC status. This has included refining original 7009 methodology with augmentation from the HRP NASA-STD-7009 Guidance Document working group and the NASA-HDBK-7009 [2]. End user requests and requirements are being satisfied as evidenced by ISS Program acceptance of IMM risk forecasts, transition to an operational model and simulation tool, and completion of service requests from a broad end user consortium including operations, science and technology planning, and exploration planning. IMM v4.0 is slated for operational release in the FY015 and current VVC assessments illustrate the expected VVC status prior to the completion of customer lead external review efforts. CONCLUSIONS: The VVC approach established by the IMM Project of incorporating Project-specific recommended practices and guidelines for implementing the 7009 requirements is comprehensive and includes the involvement of end users at every stage in IMM evolution. Methods and techniques used to quantify the VVC status of the IMM Project represented a critical communication tool in providing clear and concise suitability assessments to IMM customers. These processes have not only received approval from the local NASA community but have also garnered recognition by other federal agencies seeking to develop similar guidelines in the medical modeling community.
Document ID
20150021308
Acquisition Source
Glenn Research Center
Document Type
Presentation
Authors
Walton, M.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Boley, L.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Keenan, L.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Kerstman, E.
(Texas Univ. Galveston, TX, United States)
Shah, R.
(Texas Univ. Galveston, TX, United States)
Young, M.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Saile, L.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Garcia, Y.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Meyers, J.
(NASA Glenn Research Center Cleveland, OH, United States)
Reyes, D.
(Texas Univ. Galveston, TX, United States)
Date Acquired
November 17, 2015
Publication Date
January 13, 2015
Subject Category
Statistics And Probability
Aerospace Medicine
Report/Patent Number
GRC-E-DAA-TN20377
Meeting Information
Meeting: 2015 NASA Human Research Program Investigators'' Workshop
Location: Galveston, TX
Country: United States
Start Date: January 13, 2015
End Date: January 15, 2015
Sponsors: NASA Headquarters
Funding Number(s)
WBS: WBS 444543.01.02.10
CONTRACT_GRANT: NAS9-02078
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available